The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation
Open accessAbstract
Hepatitis C virus (HCV) RNA replication depends on viral protein association with intracellular membranes, but the influence of membrane composition on viral replication is unclear. We report that HCV RNA replication and assembly of the viral replication complex require geranylgeranylation of one or more host proteins. In cultured hepatoma cells, HCV RNA replication was disrupted by treatment with lovastatin, an inhibitor of 3-hydroxy-3-methyglutaryl CoA reductase, or with an inhibitor of protein geranylgeranyl transferase I, each of which induced the dissolution of the HCV replication complex. Viral replication was not affected by treatment of cells with an inhibitor of farnesyl transferase. When added to lovastatin-treated cells, geranylgeraniol, but not farnesol, restored replication complex assembly and viral replication. Inasmuch as the HCV genome does not encode a canonical geranylgeranylated protein, the data suggest the involvement of a geranylgeranylated host protein in HCV replication. Inhibition of its geranylgeranylation affords a therapeutic strategy for treatment of HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Self-citationBrown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citationReplication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationGenomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., & Sato, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340203 · Cited by 998
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Self-citationLiang, G., Yang, J., Horton, J. D., Hammer, R. E., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111421200 · Cited by 669
Self-citationThe statins as anticancer agents.
Chan, K., Oza, A. M., & Siu, L. L. (2003) · PubMed · Cited by 618
Ikeda, M., Yi, M., Li, K., & Lemon, S. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2997-3006.2002 · Cited by 383
Shi, S. T., Lee, K.-J., Aizaki, H., Hwang, S. B., & Lai, M. M. C. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4160-4168.2003 · Cited by 268
Wang, C., Pflugheber, J., Sumpter, R., Sodora, D. L., Hui, D., Sen, G. C., & Gale, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.3898-3912.2003 · Cited by 231
Self-citationFarci, P., Strazzera, R., Alter, H. J., Farci, S., Degioannis, D., Coiana, A., Peddis, G., Usai, F., Serra, G., Chessa, L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052712599 · Cited by 200
Hepatitis C therapeutics: current status and emerging strategies
Tan, S.-L., Pause, A., Shi, Y., & Sonenberg, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd937 · Cited by 197
Regulation of PKR and IRF-1 during hepatitis C virus RNA replication
Pflugheber, J., Fredericksen, B., Sumpter, R., Wang, C., Ware, F., Sodora, D. L., & Gale, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062055699 · Cited by 181
Self-citationStaal, A., Frith, J. C., French, M. H., Swartz, J., Güngör, T., Harrity, T. W., Tamasi, J., Rogers, M. J., & Feyen, J. H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.88 · Cited by 174
Lerner, E. C., Qian, Y., Hamilton, A. D., & Sebti, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26770 · Cited by 172
Muntz, K. H., Sternweis, P. C., Gilman, A. G., & Mumby, S. M. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.1.49 · Cited by 154
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
Beard, M. R., Abell, G., Honda, M., Carroll, A. R., Gartland, M. J., Clarke, B. E., Suzuki, K., Lanford, R. E., Sangar, D. V., & Lemon, S. M. (1999) · Hepatology · doi:10.1002/hep.510300137 · Cited by 142
El‐Hage, N., & Luo, G. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.19305-0 · Cited by 135
James, G. L., Brown, M. S., Cobb, M. H., & Goldstein, J. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47043-3 · Cited by 108
Self-citationKonan, K. V., Giddings, T. H., Ikeda, M., Li, K., Lemon, S. M., & Kirkegaard, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7843-7855.2003 · Cited by 108
THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
Forns, X., & Bukh, J. (1999) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70234-8 · Cited by 95
McHutchison, J. G., & Patel, K. (2002) · Hepatology · doi:10.1002/hep.1840360731 · Cited by 94
Wang, D., Yu, X., & Brecher, P. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33027 · Cited by 76
Use of a Prenylation Inhibitor as a Novel Antiviral Agent
Glenn, J. S., Marsters, J. C., & Greenberg, H. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9303-9306.1998 · Cited by 61
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Sumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon, S. M., & Gale, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2689-2699.2005 · Cited by 898
Self-citation
Metadata
- Authors
- Ye, J., Wang, C., Sumpter, R., Brown, M. S., Goldstein, J. L., & Gale, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-12-10
- Volume
- 100
- Issue
- 26
- Pages
- 15865-15870
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2057318017
- Cited by
- 366
- References
- 29
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.